✦ LIBER ✦

Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non-Small-Cell Lung Cancer

✍ Scribed by Riely, G. J.; Rizvi, N. A.; Kris, M. G.; Milton, D. T.; Solit, D. B.; Rosen, N.; Senturk, E.; Azzoli, C. G.; Brahmer, J. R.; Sirotnak, F. M.; Seshan, V. E.; Fogle, M.; Ginsberg, M.; Miller, V. A.; Rudin, C. M.

Book ID: 125532666
Publisher: American Society of Clinical Oncology
Year: 2009
Tongue: English
Weight: 140 KB
Volume: 27
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2008.17.4656

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase II Trial of Erlotinib A

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

✍ Janne, P. A.; Wang, X.; Socinski, M. A.; Crawford, J.; Stinchcombe, T. E.; Gu, L 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 170 KB

Randomized Phase II Study of Vandetanib

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

✍ Heymach, J. V.; Paz-Ares, L.; De Braud, F.; Sebastian, M.; Stewart, D. J.; Eberh 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 192 KB

Randomized phase II study of first-line

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer

✍ Niho, Seiji; Kunitoh, Hideo; Nokihara, Hiroshi; Horai, Takeshi; Ichinose, Yukito 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Sorafenib in combination with erlotinib

Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study

✍ Gridelli, C.; Morgillo, F.; Favaretto, A.; de Marinis, F.; Chella, A.; Cerea, G. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 125 KB

A phase III randomized study of carbopla

A phase III randomized study of carboplatin and paclitaxel with or without amifostine in patients with non-small cell lung cancer (NSCLC)

✍ Belani, C.P; Ansari, R.H; Atkins, J.N; Hon, J.K; Modiano, M.R; Budd, T.G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Randomized phase II study of concurrent

Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer

✍ Wang, Luhua; Wu, Shixiu; Ou, Guangfei; Bi, Nan; Li, Wenfeng; Ren, Hua; Cao, Jian 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 363 KB